Announcementsforthissectionshouldbesubmittedinthecorrectformatatleast3monthsbeforetherequireddateofpublication.Thislistisprovidedasaservicetoreaders;inclusiondoesnotimplyendorsementbytheHepatobiliary&PancreaticDiseasesInternational.

Sectioneditor

Shui-YingLei

Email:hbpdint@126.com

October, 2021 Rare liver diseases: Improving diagnosis and care October 22-23, 2021; Hamburg, Germany

The School for Rare Liver Diseases aims at improving clinical knowledge for both pediatric and adult hepatologists, addressing issues of transitional care, in particular, such as when pediatric liver transplant recipients become adults. In addition, organisational issues such as referral centers and the opportunities and chances through the new European Reference Network, ERN RARE-LIVER, will be discussed. Learning objectives include: 1) to describe the diagnostic trajectory of patients with autoimmune liver disease; 2) to highlight the issues that are relevant for the care of liver transplanted patients with rare liver diseases; 3) to summarize the differential diagnosis of neonatal cholestasis: disease spectrum, impact of established and novel therapies and relevance for the adult hepatologist; 4) to describe the therapeutic possibilities for polycystic liver disease; and 5) to explain the pathology and consequences of alpha-1-antitrypsin deficiency. For more informa-tion, please visit: https://easl.eu/event/hepatology-school-rare-liver-diseases/.

November Masterclass on chronic pancreatitis Online phase: November 1-30, 2021; Vienna, Austria

The UEG Masterclass comprises an innovative educational format combining online learning activities with the best features of classroom interaction and live instruction. The online phase will be spread out over the month of November 2021, with approximately 2 hours of mandatory weekly assignments. This personalized online learning experience will feature a varied mix of live and self-paced materials, including: 1) short instructional weekly videos; 2) assigned reading of clinical practice guidelines; 3) a self-paced online course on chronic pancreatitis by Julia Mayerle and Georg Beyer; and 4) live interactive webinars (Markus Lerch: Aetiology; Irene Esposito: Pathology; and Hana Algül and Irene Esposito: Basic & Translational Research). The online phase is carefully aligned with the topics and cases being covered on-site to provide an integrated learning experience. Participants will work together in multidisciplinary groups to solve clinical cases presented at the on-site meeting. For more information, please contact: Congress & Events, Ana Todorova, Tel: +43 1 997 16 39; E-mail: a.todorova@ueg.eu; Website: https://ueg.eu/education/face-to-face-education/masterclass.

Progress, pitfalls, and challenges in the management of portal hypertension November 19-20, 2021; Barcelona, Spain

The field of portal hypertension (PHT) faces many current challenges, regarding the variations in the etiology of cirrhosis. It also changes in the natural history of advanced chronic liver disease, once the etiological factors have been checked (i.e. patients’ sustained viro-logical response after receiving antiviral treatment for HCV). Topics include: 1) epidemiology and etiology of portal hypertension: Is there a world beyond cirrhosis? 2) HVPG measurement: How and when? 3) Non-invasive evaluation of portal hypertension: Does it help? 4) Update on the pharmacological and endoscopic management of portal hypertension; 5) Novel endovascular techniques: Always the last step? And 6) Precision medicine in portal hypertension: Are we there yet? With the proposed program and activities, the Barcelona Clinical School on portal hypertension will provide the following outcomes, adjusted to different needs: 1) PHT is not solely due to liver cirrhosis; 2) Etiological treatments change the natural history of advanced chronic liver disease; 3) The importance of an accurate diagnosis of the underlying disease; 4) The role of traditional diagnostic methods in the current era; 5) Better knowledge of the new therapeutic armamentarium available; 6) Evidence-based and individualised treatment of PHT; and 7) Knowing how to interpret and criticise the methodology used in clinical studies. For more information, please visit: https://easl.eu/event/hepatology-school-management-of-portal-hypertension/.

December Masterclass on chronic pancreatitis December 2-3, 2021; Vienna, Austria

The culmination of this blended learning experience will be a 2-day face-to-face event in Vienna, Austria, featuring: 1) multidisciplinary case-based learning; 2) world-class faculty; 3) a mix of teaching formats, e.g. case studies, discussion, group work, quizzes, etc.; and 4) opportunities for networking with a multidisciplinary peer group and faculty. The two days will be structured into sections covering the following topics: 1) diagnostic challenges; 2) pain management & duct drainage; 3) local complications (pseudocysts and biliary obstructions); 4) pancreatic insufficiency and cancer; and 5) how to set up a chronic pancreatitis service. Participants will work in multidisciplinary teams to solve cases prepared by faculty members in each topic block. For more information, please visit: https://ueg.eu/education/face-to-face-education/masterclass.